Login to Your Account

Week in Review

Monday, August 12, 2013


Acceleron Pharma Inc. has filed for an initial public offering (IPO) that aims to raise about $74.7 million.

Apexigen Inc. raised $20 million in a Series A1 financing to advance its cancer therapy, APX005.

Engene Inc. completed an initial closing of a $13.25 million financing led by Lumira Capital.

Intrexon Corp. priced its IPO of about 10 million shares at $16 apiece.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription